Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
How did MoneyWorks4me help subscribers to buy Tata Power at Rs. 56/ share 1 year before?

Kabra Drugs informs about standalone financial results

15 Nov 2016

Kabra Drugs has informed about Standalone Financial Results for the period ended September 30, 2016 and Standalone Limited Review for the period ended September 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Related Kabra Drugs Ltd. Links:

Kabra Drugs Share Price

5.70 0.00 (0.00%) Oct 18, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 812.55
Cipla 896.00
Dr. Reddy's Lab 4636.10
Aurobindo Pharma 695.00
Lupin 918.85
View more..
Sensex vs Kabra Drugs
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback